Ultrasound Guided Quadratus Lumborum Block Compared to Caudal Bupivacaine/ Neostigmine in Pediatric Lower Abdominal Surgeries

Phase 4

Completed

• Conditions: Postoperative Analgesia
• Interventions: Drug: bupivacaine/ neostigmine.

• Registration Number: NCT04720287
• Lead Sponsor: Ain Shams University

Brief Summary

The aim of this study is to compare the postoperative pain control in children undergoing lower abdominal surgeries receiving QL block with those receiving caudal bupivacaine/ neostigmine.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-01-19
• Study First Submitted QC: 2021-01-19
• Study First Posted: 2021-01-22
• Study Start: 2021-02-01
• Primary Completion: 2021-04-30
• Study Completion: 2021-04-30
• Status Verified: 2021-05
• Last Update Submitted: 2021-05-26
• Last Update Posted: 2021-05-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Patients American Society of Anesthesiologists physical status (ASA) I or II.
• Consent from parents or legal guardian(s).
• Lower abdominal surgeries.

Read More

Exclusion Criteria

• Parents' refusal or legal guardian's refusal.

  • Infection at the injection site.
  • Known allergy to bupivacaine and/or neostigmine.
  • Contraindications to regional anesthesia (including coagulopathy and local infection).
  • Anatomical anomalies at the site of the block.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group 1(QL group)	bupivacaine/ neostigmine.	-
Group 2 (CB group)	bupivacaine/ neostigmine.	-

Primary Outcome Measures

Name	Time	Method
The total amount of paracetamol doses (mg)	24 hours postoperatively	The total amount of paracetamol doses (mg)

Trial Locations

Locations (1)

Ain-Shams University Hospitals; 🇪🇬 Cairo, Egypt